Dibutyltin dilaurate induced thymic atrophy and modulation of phosphoinositide pathway of cell signalling in thymocytes of rats.
A marked dose dependent reduction in thymus weight and its nucleated cell counts with histological alterations was observed in rats exposed to oral dibutyltin dilaurate (DBTL) for 2 weeks at 2, 4, 8 or 16 mg/kg body weight. The incorporation of [3H]-inositol into all the three major phosphoinositides was drastically reduced in thymocytes in a dose dependent manner. Furthermore, the basal and the mitogen (Con A) stimulated [3H]-inositol phosphates generation was diminished significantly in 8 mg DBTL group. However, in vitro incubation of DBTL with thymocytes failed to evoke any change in phosphoinositide hydrolysis. Similarly, a time and dose dependent inhibition in phosphoinositide synthesis with as high as 80% by 10 microM DBTL was exhibited under in vitro conditions. A 130% and 600% enhancement of protein kinase C (PKC) activity in thymocytes was seen in 4 mg and 8 mg DBTL group, respectively. Addition of DBTL to the cell free assay system of thymocytes resulted in a concentration dependent activation of the enzyme activity. A dose dependent increase in intracellular calcium was also evident when DBTL was added to thymocytes under in vitro conditions. These results are of significance and may bear close relationship to the observed thymic atrophy by DBTL.
Subramoniam
A
A
Immunotoxicology Division, Industrial Toxicology Research Centre, Lucknow, India.
Khandelwal
S
S
Dwivedi
P D
PD
Khanna
S
S
Shanker
R
R
D000818:Animals; D001284:Atrophy / Q000139:chemically induced; D002118:Calcium / Q000378:metabolism; D066298:In Vitro Techniques; D008221:Lymphoid Tissue / Q000187:drug effects; D008297:Male; D009929:Organ Size / Q000187:drug effects; D009947:Organotin Compounds / Q000633:toxicity*; D010716:Phosphatidylinositols / Q000378:metabolism; D011493:Protein Kinase C / Q000187:drug effects; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects*; D013950:Thymus Gland / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology
D009947:Organotin Compounds; D010716:Phosphatidylinositols; D011493:Protein Kinase C; C010409:dibutyltin dilaurate; D002118:Calcium